secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAXCYTE, INC. (MXCT)
CIK:        0001287098
Form:       8-K
Filed at:   2026-03-27T23:59:59+00:00
Accession:  0001104659-26-036201
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MaxCyte appoints Parmeet Ahuja as CFO effective March 30, 2026
--------------------------------------------------------------

- Parmeet Ahuja succeeds Douglas Swirsky, who is transitioning from the role as announced in November 2025.
- Ahuja brings over 20 years of finance leadership at Agilent, most recently as VP, Investor Relations.
- He will receive an annual base salary of $450,000 and a target cash bonus of 50% of base salary.
- Inducement equity: option for 375,000 shares and RSU for 187,500 shares of common stock.
- Severance agreement provides for 12 months base salary and COBRA upon change-of-control termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1287098/000110465926036201/0001104659-26-036201-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1287098/000110465926036201/mxct-20260323x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-036201

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer